ursodeoxycholic acid has been researched along with Idiopathic Parkinson Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aasly, J; Bandmann, O; Cameron, SA; Clemmens, H; Furneaux, RH; Harris, LD; Hastings, C; Luxenburger, A; Mortiboys, H; Ure, EM; Weymouth-Wilson, A | 1 |
| Appleby, M; Bandmann, O; Buckley, E; Dunning, MJ; Foltynie, T; Hernandez, D; Jenkins, TM; Libri, V; Marchesi, JR; Mazzà, C; McNeill, A; Moll, S; Mullish, BH; Payne, T; Sassani, M; Scholz, SW; Su, L; Taylor, R; van Gelder, LMA | 1 |
| Chen, C; Chen, W; Cloyd, J; Coles, LD; Lee, BY; Low, WC; Ma, Y; Sathe, AG; Steer, CJ; Tuite, P; Zhu, XH | 1 |
| Bandmann, O; Carling, PJ; Clemmens, H; Evetts, S; Ferraiuolo, L; Green, C; Hastings, C; Hide, W; Hu, MT; Hughes, R; Lo, C; Mihaylov, S; Mortiboys, H; Payne, T; Sandor, C; Schwartzentruber, A; Talbot, K; Taylor, R; Wade-Martins, R; Webber, C; Wei, W; Willcox, S; Wong, S; Wyles, M | 1 |
| Beggiato, S; Dalpiaz, A; de Oliveira Junior, ER; Ferraro, L; Fogagnolo, M; Leo, E; Lima, EM; Maretti, E; Pavan, B; Rustichelli, C; Truzzi, E | 1 |
| Anton, A; Appleby, M; Bandmann, O; Buckley, E; Foltynie, T; Hoggard, N; Jenkins, T; Maru, S; Mazza, C; McNeill, A; Moll, S; Payne, T; Sassani, M; Taylor, R; Wilkinson, ID | 1 |
| Aasly, J; Bandmann, O; Mortiboys, H | 1 |
| Abdelkader, NF; Safar, MM; Salem, HA | 1 |
| Gasser, T; Greenamyre, JT; Sanders, LH | 1 |
| Aasly, J; Bandmann, O; Bronstad, G; Elliott, C; Furmston, R; Mortiboys, H | 1 |
3 trial(s) available for ursodeoxycholic acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.
Topics: Double-Blind Method; Humans; Parkinson Disease; Ursodeoxycholic Acid | 2023 |
Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease-A Pilot Study.
Topics: Adenosine Triphosphate; Administration, Oral; Aged; Brain; Cognition; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pilot Projects; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study.
Topics: Disease Progression; Double-Blind Method; England; Humans; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
7 other study(ies) available for ursodeoxycholic acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
3α,7-Dihydroxy-14(13→12)
Topics: Bile Acids and Salts; Cholanes; Humans; Parkinson Disease; Ursodeoxycholic Acid | 2022 |
Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease.
Topics: Aged; Cell Differentiation; Cells, Cultured; Female; Fibroblasts; Gene Expression Profiling; Humans; Lysosomes; Male; Middle Aged; Mitochondria; Neurons; Parkinson Disease; Phenotype; Transcriptome; Ursodeoxycholic Acid | 2020 |
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease.
Topics: Acyclic Monoterpenes; Administration, Intranasal; Animals; Antiparkinson Agents; Parkinson Disease; Rats; Ursodeoxycholic Acid | 2020 |
Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease.
Topics: Adult; Cholic Acids; Humans; Membrane Potential, Mitochondrial; Middle Aged; Mitochondria; Mutation; Neurons; Parkinson Disease; Ursodeoxycholic Acid | 2013 |
Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Behavior, Animal; Caspases; Disease Models, Animal; Dopamine; Gene Expression Regulation; Male; Mitochondria; Neostriatum; Neurons; Parkinson Disease; Rats, Wistar; RNA, Messenger; Rotenone; Ursodeoxycholic Acid | 2016 |
Fruit flies, bile acids, and Parkinson disease: a mitochondrial connection?
Topics: Animals; Female; Heterozygote; Humans; Male; Mitochondria; Parkinson Disease; Protein Serine-Threonine Kinases; Ursodeoxycholic Acid | 2015 |
UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo.
Topics: Adult; Aged; Animals; Animals, Genetically Modified; Drosophila; Female; Heterozygote; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mitochondria; Parkinson Disease; Protein Serine-Threonine Kinases; Treatment Outcome; Ursodeoxycholic Acid | 2015 |